Navigation Links
IDIBELL license to Minoryx a patent of a product to treat a rare neurodegenerative disease
Date:5/7/2013

The Bellvittge Biomedical Research Institute (IDIBELL) has signed a licensing agreement with the Spanish biotechnology company Minoryx of a patent for the treatment of X-linked adrenoleukodystrophy, a rare serious neurodegenerative disease which has no effective treatment.

The Neurometabolic Diseases group led by ICREA researcher Aurora Pujol, has developed an animal model to study this disease. Studies using this model have shown that the patented product, a repositioned drug, may be effective against X-linked adrenoleukodystrophy.

The obtaining of the patent and the license has been managed by the Technology Transfer Office of IDIBELL. The license represents an opportunity not only to get this invention into the market and patients, but also to initiate a partnership of trust between the company and IDIBELL in developing new solutions to improve the quality of life of patients with adrenoleukodystrophy.

Hereditary disease

The X-linked adrenoleukodystrophy is an inherited disease that destroys the myelin (white matter that coats the nerves) at the central or peripheral nervous system and causes hormonal changes. Patients have a genetic mutation that impedes the properly degradation of very long chain fatty acids within cells. This causes the accumulation of this type of fat in plasma and tissues, especially in the brain and adrenal gland, causing irreversible damage.

This is a rare disease that affects only male subjects, although female carriers may also experience some symptoms. Its incidence is one case per 17,000 men. It is the most common type of leukodystrophy and the main peroxisome disorder. The peroxisome is the part of the cell responsible for eliminating toxic products. The disease became famous in 1992 with the film Lorenzo's oil, starring by Nick Nolte and Susan Sarandon.

Pioglitazone acts on the nuclear receptor PPAR-gamma and to a lesser extent, on PPAR-alpha. These are proteins that r
'/>"/>

Contact: Arantxa Mena
comunicacio@idibell.cat
34-932-607-129
IDIBELL-Bellvitge Biomedical Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Coding Certiifcation.Org Under License With the AAPC, Adds Certified Physician Practice Manager to their Product Course Offerings
2. Cosmetic Surgery – Protecting Consumers from Unlicensed Practitioners
3. Dr. Stephen Lazarus Continues to Recognize the Importance of Quality, Medical Skin Care and Products in Welcoming Licensed Paramedical Esthetician, Amye Smith
4. CodingCertification.Org (CCO) Enters a License Agreement With the AAPC to Add the Professional Medical Coding Curriculum (PMCC) to its Course Offerings
5. EverCheck: Healthcare, Human Resources, & License Verification
6. Bridges to Recovery Reaches Ten-Year Milestone as Premiere, Licensed Residential Behavioral Treatment Program and Honors Founding Medical Director Dr. Terry V. Eagan
7. University of Minnesota licenses Clinical Decision Support technology
8. Patent Issued for Apparel and Textile Fabric with Antimicrobial Properties
9. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
10. Human Gene Patent Case Goes to Supreme Court
11. A New Alarm Clock App (Patent Pending) Helps to Lose Weight and Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... (PRWEB) March 28, 2015 Thousands ... devices manufactured by C.R. Bard, Inc. continue to ... U.S. District Court, Southern District of West Virginia, ... serving on the Plaintiffs’ Steering Committee. According ... has granted certain defendants named in those lawsuits ...
(Date:3/28/2015)... 2015 India Network visitor health ... available to all visitors who purchase the plan before ... are encouraged to purchase the insurance program as soon ... proper coverage for pre-existing medical conditions. Parents and grandparents ... medical conditions with serious consequences to their health. Many ...
(Date:3/28/2015)... Pitching speed, player’s height, and pitching for multiple ... injuries, according to new research released today at the American ... , “Our findings indicate that a 10 inch increase in ... a history of injury, a 10 mile per hour increase ... a history of injury, and playing for more than one ...
(Date:3/28/2015)... March 28, 2015 Delaying rotator cuff ... necessary, according to research presented today at the American ... Day. , “Our study compared results for 170 patients ... an additional glenohumeral joint capsule release procedure to relieve ... MD, PhD, lead author from St. George Hospital in ...
(Date:3/28/2015)... March 28, 2015 Andrew Hawley of Vintage ... Who psychedelic concert posters. The Who and the Doors played ... August 2, 1968. According to Hawley, “The Who toured the ... halls and college campuses. Perhaps the most famous Who poster ... Morrison and the Doors on August 2, 1968 at the ...
Breaking Medicine News(10 mins):Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2
... community of more than 60,000 medical device and diagnostics professionals. ... ... DeviceSpace.com , an onTargetjobs Inc. company and the nation,s premier job ... MedicalDeviceLink.com to launch Device Career Network , a ...
... one week in January Radiotherapy Clinics of Georgia ... promote prostate cancer educational outreach. Called the ,Prostate ... men throughout metro Atlanta with potential life-saving full ... the home of RCOG, the only source for ...
... La Jolla cosmetic dermatologist, Dr. William F. Groff, at La Jolla Cosmetic ... laser technology for pearly penile papules treatment . , ... La ... any physical health problems, pearly penile papules do affect a ...
... women with cancers of the uterus are less likely to ... has been made over the past two decades to narrow ... study published in the March 15, 2009 issue of ... , While previous research has shown that black women are ...
... L & C Internet Enterprises, Inc. has structured a ... the demise of their practice for lack of income. ... on the table all because physicians are never taught ... their medical practice using effective self-marketing. The ...
... and less cell degeneration , , SUNDAY, Feb. 8 ... able to slow or stop Alzheimer,s disease in recent ... brain,s entorhinal cortex, which supports memory, normally produces brain-derived ... when Alzheimer,s is present. When researchers injected BDNF in ...
Cached Medicine News:Health News:DeviceSpace and Medical Device Link Launch Dynamic, Online Career Center 2Health News:DeviceSpace and Medical Device Link Launch Dynamic, Online Career Center 3Health News:RCOG Completes Successful Atlanta Community Prostate Cancer Screening 2Health News:RCOG Completes Successful Atlanta Community Prostate Cancer Screening 3Health News:Pearly Penile Papule Patients Can Successfully Be Treated with Targeted CO2 Technology at La Jolla Cosmetic Surgery Centre 2Health News:Pearly Penile Papule Patients Can Successfully Be Treated with Targeted CO2 Technology at La Jolla Cosmetic Surgery Centre 3Health News:Black women with uterine cancers more likely to die than white patients 2Health News:Unbelievable Lack Of Marketing Knowledge Forces Doctors To Quit Practice. 2Health News:Unbelievable Lack Of Marketing Knowledge Forces Doctors To Quit Practice. 3Health News:Brain Protein May Have Potential Against Alzheimer's 2
(Date:3/27/2015)... According to a new market research report ... Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, ... Global Forecasts to 2019 ", published by MarketsandMarkets, the Electrophysiology ... by 2019 with a CAGR of around 10.3% during ... Browse   90   ma rket data T ...
(Date:3/27/2015)... 2015   Hospira, Inc. (NYSE: ... the world,s leading provider of injectable drugs and ... evaluation of biosimilarity of its proposed biosimilar, Epoetin ... (FDA) conditionally approved name of RETACRIT™, compared to ... study data were presented at the National Kidney ...
(Date:3/27/2015)... , March 27, 2015 ... 2015" therapeutic market research report of 52 pages ... online business intelligence library. The report ... on the therapeutic development for Visceral Pain, complete ... by drug target, mechanism of action (MoA), route ...
Breaking Medicine Technology:Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4
... a world-leading developer and marketer of innovative medical technologies ... Ltd, a wholly-owned subsidiary of ConvaTec Holdings UK Ltd, ... a UK-based company that specialises in the discreet home ... As a well-respected company in the home ...
... President and CEO Randall Moreadith, MD, PhD, reported today that ... advance its lead oncology candidate SER-203 into a Phase I ... pleased to report to our existing and new shareholders the ... 2010. This is a very significant milestone for Serina Therapeutics, ...
Cached Medicine Technology:ConvaTec Announces Acquisition of Trent Direct 2Serina Therapeutics, Inc. Closes $9.5 Million Financing Round 2
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride, 0.5% Yeast Extract, 1.0% bacto casamino acids, 0.2% Mag. Sulfate....
0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride, 10mM Magnesium Chloride, 10mM Mag. Sulfate....
Innovative hemi device combining anatomic design with the advanced material pyrocarbon....
3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5....
Medicine Products: